Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.92EUR
−67.64 MEUR
96.35 MEUR
371.07 M
About Standard BioTools Inc.
Sector
Industry
CEO
Michael Egholm
Website
Headquarters
South San Francisco
Employees (FY)
539
Founded
1999
Standard BioTools Inc. engages in the provision of biotechnology tools and services for clinical research. It sells preparatory and analytical instruments for mass cytometry, polymerase chain reaction, library prep, single cell genomics, and consumables including integrated fluidic circuits (IFCs), assays, and reagents. The company was founded by Stephen D. Quake and Gajus Vincent Worthington on May 19, 1999 and is headquartered in South San Francisco, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of FLB is 2.36 EUR — it hasn't changed in the past 24 hours. Watch STANDARD BIOTOOLS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange STANDARD BIOTOOLS INC stocks are traded under the ticker FLB.
FLB stock has risen by 0.85% compared to the previous week, the last month showed zero change in price, over the last year STANDARD BIOTOOLS INC has showed a 4.42% increase.
We've gathered analysts' opinions on STANDARD BIOTOOLS INC future price: according to them, FLB price has a max estimate of 3.76 EUR and a min estimate of 3.06 EUR. Watch FLB chart and read a more detailed STANDARD BIOTOOLS INC stock forecast: see what analysts think of STANDARD BIOTOOLS INC and suggest that you do with its stocks.
FLB stock is 0% volatile and has beta coefficient of 0.84. Track STANDARD BIOTOOLS INC stock price on the chart and check out the list of the most volatile stocks — is STANDARD BIOTOOLS INC there?
Today STANDARD BIOTOOLS INC has the market capitalization of 910.48 M, it has decreased by 2.85% over the last week.
Yes, you can track STANDARD BIOTOOLS INC financials in yearly and quarterly reports right on TradingView.
STANDARD BIOTOOLS INC is going to release the next earnings report on Aug 7, 2024. Keep track of upcoming events with our Earnings Calendar.
FLB earnings for the last quarter are −0.25 EUR per share, whereas the estimation was −0.10 EUR resulting in a −140.25% surprise. The estimated earnings for the next quarter are −0.08 EUR per share. See more details about STANDARD BIOTOOLS INC earnings.
STANDARD BIOTOOLS INC revenue for the last quarter amounts to 42.21 M EUR despite the estimated figure of 42.64 M EUR. In the next quarter revenue is expected to reach 44.45 M EUR.
FLB net income for the last quarter is −29.80 M EUR, while the quarter before that showed −17.92 M EUR of net income which accounts for −66.33% change. Track more STANDARD BIOTOOLS INC financial stats to get the full picture.
No, FLB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 22, 2024, the company has 539.00 employees. See our rating of the largest employees — is STANDARD BIOTOOLS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. STANDARD BIOTOOLS INC EBITDA is −64.52 M EUR, and current EBITDA margin is −45.01%. See more stats in STANDARD BIOTOOLS INC financial statements.
Like other stocks, FLB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade STANDARD BIOTOOLS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So STANDARD BIOTOOLS INC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating STANDARD BIOTOOLS INC stock shows the neutral signal. See more of STANDARD BIOTOOLS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.